Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Canadian Adaptive Platform Trial of Treatments for COVID-19 in Community Settings

NCT05614349 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT05614349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05614349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Canadian Adaptive Platform Trial of Treatments for COVID-19 in Community Settings
Lead sponsor
Unity Health Toronto
Phase
Phase 3
Overall status
Active, not recruiting
Start date
January 16, 2023
Completion date
June 28, 2025
Enrollment
797 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19